Home / Share Price Target / Vantabio
Vanta Bioscience Share Price Target 2024, 2025, 2026 to 2039 With Charts
Vanta Bioscience Limited | |||
 | Symbol: VANTABIO | ||
| Price: ₹41.07 | |||
| Exchange: BSE | |||
| -> | |||
Show Table of Contents
Table of Contents
- 0.1: Vanta Bioscience Financial Performance
- 0.1.1: Is Vanta Bioscience A Good Buy For Long Term?
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Vanta Bioscience Share Price Target For 2024
- 1.1.1: Vanta Bioscience Share Price Target Table For 2024
- 1.1.2: Summary: Vanta Bioscience Share Price Prediction For 2024
- 1.2: Vanta Bioscience Share Price Target For 2025
- 1.2.1: Vanta Bioscience Share Price Target Table For 2025
- 1.2.2: Summary: Vanta Bioscience Share Price Prediction For 2025
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Vanta Bioscience Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 2.2: Vanta Bioscience Share Price Target Table From 2024, 2025, 2026 to 2039
- 3: Vanta Bioscience Past Performance
Vanta Bioscience Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 46.39 Crore | Market valuation of Vanta Bioscience's shares. |
| Revenue (TTM) | 6.27 Crore | Total revenue generated by Vanta Bioscience over the past twelve months. |
| Net Income (TTM) | -6.48 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -74.22% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 84.24% | Net income as a percentage of revenue, after all expenses. |
| Debt-to-Equity (D/E) Ratio | 2.95 | Company's total debt divided by total shareholder equity. |
| Total Debt | 57.11 Crore | Sum of Vanta Bioscience's current & long-term financial obligations. |
Is Vanta Bioscience A Good Buy For Long Term?
Vanta Bioscience, a small-cap stock with a volatile history, shows mixed financial performance. Its recent revenue growth is promising, but its profitability remains a concern with negative net income. The high debt level of 57.11 Crore raises financial risk. While past returns have been positive in the short term, long-term returns have been negative. Given these factors, Vanta Bioscience may be considered an average buy for investors seeking moderate risk with the potential for growth, but caution is advised due to its financial vulnerabilities.
To predict the Vanta Bioscience's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Vanta Bioscience Share Price Target For 2024
The line chart displays the monthly closing prices of Vanta Bioscience with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Vanta Bioscience shares in 2024, see the table below.
Vanta Bioscience Share Price Target Table For 2024
| Vanta Bioscience's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 42.89 (+4.43%) | Price Action: 18 Oct 2024 High |
| 2024 Target 2 | 42.17 (+2.67%) | Price Action: Chart |
| 2024 Target 1 | 41.75 (+1.65%) | Price Action: Sep 2023 Low |
| Current Price | 41.07 | Vanta Bioscience's 1 share price as of Tue 19 Nov 2024 |
| Stop Loss 1 | 40.74 (-0.81%) | Price Action: 22 Oct 2024 High |
| Stop Loss 2 | 40.29 (-1.9%) | Price Action: 23 Oct 2024 High |
| Stop Loss 3 | 39.71 (-3.32%) | Price Action: Oct 2023 Low |
Summary: Vanta Bioscience Share Price Prediction For 2024
In summary, Vanta Bioscience has declined by ₹-12.48, recording a notable -23.31% decrease from 1st January 2024 to 19 Nov 2024. Despite the setback, our analysis of Vanta Bioscience for 2024 predicts an additional rise of 1.65% to 4.43% by the end of 2024 with three potential targets T1: 41.75, T2: 42.17, T3: 42.89. Stop Loss at SL1: 40.74, SL2: 40.29, SL3: 39.71.
Vanta Bioscience has a 52-week high of ₹101.64, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹37.01, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Vanta Bioscience.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Vanta Bioscience Share Price Target For 2025
The line chart displays the monthly closing prices of Vanta Bioscience with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Vanta Bioscience shares in 2025, see the table below.
Vanta Bioscience Share Price Target Table For 2025
| Vanta Bioscience's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 85.44 (+108.03%) | Price Action: Chart |
| 2025 Target 2 | 83.85 (+104.16%) | Price Action: Chart |
| 2025 Target 1 | 83.02 (+102.14%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 41.07 | Vanta Bioscience's 1 share price as of Tue 19 Nov 2024 |
| Stop Loss 1 | 30.85 (-24.89%) | Price Action: Chart |
| Stop Loss 2 | 30.54 (-25.64%) | Price Action: Chart |
| Stop Loss 3 | 29.99 (-26.98%) | Price Action: Chart |
Summary: Vanta Bioscience Share Price Prediction For 2025
In summary, Vanta Bioscience has declined by ₹-12.48, recording a notable -23.31% decrease from 1st January 2024 to 19 Nov 2024. Despite the setback, our analysis of Vanta Bioscience for 2025 predicts an additional rise of 102.14% to 108.03% by the end of 2025 with three potential targets T1: 83.02, T2: 83.85, T3: 85.44. Stop Loss at SL1: 30.85, SL2: 30.54, SL3: 29.99.
Vanta Bioscience has a All-Time high of ₹195.50, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹37.01, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Vanta Bioscience, we have created a specific page for that check here: Vanta Bioscience Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Vanta Bioscience Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Vanta Bioscience share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of -0.2% over the next 15 years.
For complete year by year Vanta Bioscience long term share price target from 2024, 2025 to 2039 check the below table.
Vanta Bioscience Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Vanta Bioscience Target | YoY Change % |
|---|---|---|
| 2024 | ₹41.07 | [Current Price] |
| 2024 | ₹42.91 | 4.48% |
| 2025 | ₹31.24 | -27.2% |
| 2026 | ₹36.56 | 17.02% |
| 2027 | ₹38.86 | 6.31% |
| 2028 | ₹38.4 | -1.21% |
| 2029 | ₹44.8 | 16.66% |
| 2030 | ₹44.73 | -0.16% |
| 2031 | ₹39.75 | -11.14% |
| 2032 | ₹37.93 | -4.58% |
| 2033 | ₹46.54 | 22.69% |
| 2034 | ₹46.27 | -0.59% |
| 2035 | ₹44.49 | -3.85% |
| 2036 | ₹45.39 | 2.02% |
| 2037 | ₹42.08 | -7.3% |
| 2038 | ₹39.69 | -5.68% |
| 2039 | ₹41.73 | 5.13% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Vanta Bioscience Past Performance
- In 2017, Vanta Bioscience opening price was ₹51.5
- As of Tue 19 Nov 2024 the price stands at ₹41.07.
- This represents a Compound Annual Growth Rate (CAGR) of -2.79%.
- In 7 years, an investment of 10,000 would have become ₹7,974.75.
As we wrap up, we hope you like our study on Vanta Bioscience share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
